Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 1
2006 1
2007 2
2008 2
2009 1
2010 2
2011 2
2012 1
2013 1
2014 1
2015 1
2021 1
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic changes in the plasma of mild Alzheimer's disease patients treated with Hachimijiogan.
Kainuma M, Kawakatsu S, Kim JD, Ouma S, Iritani O, Yamashita KI, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y. Kainuma M, et al. Among authors: kajimoto y. Front Pharmacol. 2023 Jun 12;14:1203349. doi: 10.3389/fphar.2023.1203349. eCollection 2023. Front Pharmacol. 2023. PMID: 37377927 Free PMC article.
An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease.
Kainuma M, Ouma S, Kawakatsu S, Iritani O, Yamashita KI, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y. Kainuma M, et al. Among authors: kajimoto y. Front Pharmacol. 2022 Oct 14;13:991982. doi: 10.3389/fphar.2022.991982. eCollection 2022. Front Pharmacol. 2022. PMID: 36313371 Free PMC article.
Predictive value of the neutrophil-to-lymphocyte ratio for treatment response in patients diagnosed with definite or probable autoimmune encephalitis/encephalopathy.
Ogami S, Koh J, Miyamoto K, Mori M, Takahashi M, Nakayama Y, Sakata M, Hiwatani Y, Kajimoto Y, Ishiguchi H, Ito H. Ogami S, et al. Among authors: kajimoto y. Front Neurol. 2023 Oct 23;14:1284717. doi: 10.3389/fneur.2023.1284717. eCollection 2023. Front Neurol. 2023. PMID: 37936916 Free PMC article.
Efficacy and safety of istradefylline in patients with Parkinson's disease presenting with postural abnormalities: Results from a multicenter, prospective, and open-label exploratory study in Japan.
Takahashi M, Shimokawa T, Koh J, Takeshima T, Yamashita H, Kajimoto Y, Mori A, Ito H. Takahashi M, et al. Among authors: kajimoto y. J Neurol Sci. 2022 Jan 15;432:120078. doi: 10.1016/j.jns.2021.120078. Epub 2021 Dec 4. J Neurol Sci. 2022. PMID: 34923334 Free article.
Risk Factors for Therapeutic Intervention of Remdesivir in Mild to Moderate COVID-19-A Single-Center Retrospective Study of the COVID-19 Fourth Pandemic Period in Wakayama, Japan.
Tamura S, Kaki T, Niwa M, Yamano Y, Kawai S, Yamashita Y, Tanaka H, Saito Y, Kajimoto Y, Koizumi Y, Yamaue H, Nakao N, Nojiri T, Hironishi M. Tamura S, et al. Among authors: kajimoto y. Medicina (Kaunas). 2022 Jan 13;58(1):118. doi: 10.3390/medicina58010118. Medicina (Kaunas). 2022. PMID: 35056426 Free PMC article.
25 results